TRCT
IBBJ

Tower Research Capital (TRC)’s Defiance Nasdaq Junior Biotechnology ETF IBBJ Stock Holding History

Tower Research Capital (TRC)’s Portfolio IBBJ Stock Details IBBJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,070
Closed -$231K – 6540
2021
Q2 		$231K Sell
7,070
-1,824
-21% -$57.7K 0.01% 1807
2021
Q1 		$296K Sell
8,894
-14,502
-62% -$527K 0.01% 1675
2020
Q4 		$806K Buy
+23,396
New +$718K 0.02% 633

Other funds holding IBBJ

IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
IF
Ironwood Financial Tucson, Arizona $639M AUM 19.03% 1-Year Est. Return
EIP
Ellis Investment Partners Berwyn, Pennsylvania $660M AUM 26.32% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Tower Research Capital (TRC)'s IBBJ Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Q3 2021, closing a stake of 7,070 shares — an estimated $231K sold.

Tower Research Capital (TRC) first reported a position in IBBJ in Q4 2020 and held it in 3 quarters. The position peaked at $806K in Q4 2020. 9 funds tracked by Wall St. Rank hold IBBJ as of Q3 2021.

  • Tower Research Capital (TRC) reported no remaining Defiance Nasdaq Junior Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 7,070 Defiance Nasdaq Junior Biotechnology ETF shares in Q3 2021, an estimated $231K.
  • Tower Research Capital (TRC) first reported a position in Defiance Nasdaq Junior Biotechnology ETF in Q4 2020 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Defiance Nasdaq Junior Biotechnology ETF position peaked at $806K in Q4 2020.
  • 9 funds tracked by Wall St. Rank held Defiance Nasdaq Junior Biotechnology ETF as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.